Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A Multicenter, Open-Label Study of Posaconazole Oral Suspension in Treatment of Patients with Invasive Fungal Infection Refractory to or Intolerant of First-Line Therapy,

Xiaojun Huang, Fengrong Wang, Yuhong Chen, MD, PhD, Ting Liu, MD, Jianxiang Wang, MD, Jianda Hu, PhD, Jie Jin, MD, Fangping Chen, Shujie Wang, MD, PhD, Zhixiang Shen, MD, PhD, Li Yu, Kang Yu, Yingmin Liang

Blood (2011) 118 (21): 3241.

https://doi.org/10.1182/blood.V118.21.3241.3241

Published: 2011

Journal Articles

A Multicenter, Randomized, Open-Label Study to Evaluate Safety and Efficacy of Posaconazole Vs Fluconazole in the Prophylaxis of Invasive Fungal Infection in a Chinese Population

Shen Yang, MD, Xiaojun Huang, Jianxiang Wang, MD, Jie Jin, PhD, Jianda Hu, PhD, Kang Yu, Depei Wu, MD, Shujie Wang, MD, PhD, Li Yu, Xiequn Chen, Ting Liu, MD, Yingmin Liang, Chen Fangping, MD, Yan Li, MD, Zhixiang Shen, MD, PhD

Blood (2011) 118 (21): 4916.

https://doi.org/10.1182/blood.V118.21.4916.4916

Published: 2011

Journal Articles

Survival Outcomes of Hematopoietic Stem Cell Transplantation (HSCT) and Imatinib in the Treatment of Chronic Myeloid Leukemia Treatment in China: a Meta-Analysis.

Xiaojun Huang, MD, PhD, Zhixiang Shen, MD, PhD, Zi Chen, Yang Cao, MD, Ph.D., Xiaoping Xu, MD, Ph.D., Qiang Wang, Ph.D., Samara Mendes de Costa, Henry Dummett, Jie Chen, MD, Ph.D.

Blood (2009) 114 (22): 2497.

https://doi.org/10.1182/blood.V114.22.2497.2497

Published: 2009

Journal Articles

Cost-Effectiveness of Imatinib in Comparison with Bone Marrow Transplant in Chronic Phase (CP) Chronic Myeloid Leukaemia (CML) in China.

Zhixiang Shen, MD, PhD, Xiaojun Huang, MD, PhD, Samara Mendes de Costa, Zi Chen, Xiaoping Xu, MD, Ph.D., Qiang Wang, Ph.D., Jie Chen, MD, Ph.D.

Blood (2009) 114 (22): 2474.

https://doi.org/10.1182/blood.V114.22.2474.2474

Published: 2009

Journal Articles

A Worldwide Observational Registry Collecting Longitudinal Data On the Management of CML Patients (The WORLD CML Registry) - Summary of the First 1001 Patients.

Ricardo Pasquini, MD, Jorge Cortes-Franco, MD, Hagop M. Kantarjian, MD, David Joske, MBBS, FRCPA, FRACP, Zhixiang Shen, MD, PhD, Luis Meillon, MD, Lidia Mongay, MD, PhD, MBA, Dawn F. Eng, Jim Wang, PhD, Timothy P. Hughes, MD, MBBS, Dong-Wook Kim, MD, PhD

Blood (2009) 114 (22): 4267.

https://doi.org/10.1182/blood.V114.22.4267.4267

Published: 2009

NARROW

A Multicenter, Open-Label Study of Posaconazole Oral Suspension in Treatment of Patients with Invasive Fungal Infection Refractory to or Intolerant of First-Line Therapy,

A Multicenter, Randomized, Open-Label Study to Evaluate Safety and Efficacy of Posaconazole Vs Fluconazole in the Prophylaxis of Invasive Fungal Infection in a Chinese Population

Survival Outcomes of Hematopoietic Stem Cell Transplantation (HSCT) and Imatinib in the Treatment of Chronic Myeloid Leukemia Treatment in China: a Meta-Analysis.

Cost-Effectiveness of Imatinib in Comparison with Bone Marrow Transplant in Chronic Phase (CP) Chronic Myeloid Leukaemia (CML) in China.

A Worldwide Observational Registry Collecting Longitudinal Data On the Management of CML Patients (The WORLD CML Registry) - Summary of the First 1001 Patients.

Email alerts

ASH Publications

American Society of Hematology

A Multicenter, Open-Label Study of Posaconazole Oral Suspension in Treatment of Patients with Invasive Fungal Infection Refractory to or Intolerant of First-Line Therapy,

A Multicenter, Randomized, Open-Label Study to Evaluate Safety and Efficacy of Posaconazole Vs Fluconazole in the Prophylaxis of Invasive Fungal Infection in a Chinese Population

Survival Outcomes of Hematopoietic Stem Cell Transplantation (HSCT) and Imatinib in the Treatment of Chronic Myeloid Leukemia Treatment in China: a Meta-Analysis.

Cost-Effectiveness of Imatinib in Comparison with Bone Marrow Transplant in Chronic Phase (CP) Chronic Myeloid Leukaemia (CML) in China.

A Worldwide Observational Registry Collecting Longitudinal Data On the Management of CML Patients (The WORLD CML Registry) - Summary of the First 1001 Patients.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only